| Protein arginine methyltransferase 5 promotes cholesterol biosynthesis–mediated Th17 responses and autoimmunity LM Webb, S Sengupta, C Edell, ZL Piedra-Quintero, SA Amici, ... The Journal of clinical investigation 130 (4), 1683-1698, 2020 | 53 | 2020 |
| Targeting phosphatidylinositol 3 kinase-β and-δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma N Jain, S Singh, G Laliotis, A Hart, E Muhowski, K Kupcova, T Chrbolkova, ... Blood Advances 4 (18), 4382-4392, 2020 | 24 | 2020 |
| Integration of metabolomics and gene expression profiling elucidates IL4I1 as modulator of ibrutinib resistance in ABC-diffuse large B cell lymphoma F Choueiry, S Singh, A Sircar, G Laliotis, X Sun, E Chavdoula, S Zhang, ... Cancers 13 (9), 2146, 2021 | 14 | 2021 |
| Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer. SA Cohen, PM Kasi, VN Aushev, DL Hanna, GP Botta, S Sharif, ... Journal of clinical oncology 41 (4_suppl), 5-5, 2023 | 12 | 2023 |
| RNAdetector: a free user-friendly stand-alone and cloud-based system for RNA-Seq data analysis A La Ferlita, S Alaimo, S Di Bella, E Martorana, GI Laliotis, F Bertoni, ... BMC bioinformatics 22 (1), 298, 2021 | 12 | 2021 |
| Interpretable deep learning for chromatin-informed inference of transcriptional programs driven by somatic alterations across cancers Y Tao, X Ma, D Palmer, R Schwartz, X Lu, HU Osmanbeyoglu Nucleic Acids Research 50 (19), 10869-10881, 2022 | 7 | 2022 |
| The present and future of clinical management in metastatic breast cancer PH Lin, G Laliotis Journal of clinical medicine 11 (19), 5891, 2022 | 6 | 2022 |
| The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation E Ladewig, F Michelini, K Jhaveri, P Castel, J Carmona, L Fairchild, ... Cancer research 82 (12), 2269-2280, 2022 | 6 | 2022 |
| PRMT5 promotes symmetric dimethylation of RNA processing proteins and modulates activated T cell alternative splicing and Ca2+/NFAT signaling S Sengupta, KO West, S Sanghvi, G Laliotis, LM Agosto, KW Lynch, ... Immunohorizons 5 (10), 884-897, 2021 | 6 | 2021 |
| Use of cetuximab added to weekly chemotherapy to improve progression-free survival in patients with recurrent metastatic head and neck squamous cell carcinoma after progression … M Issa, B Klamer, V Karivedu, P Bhateja, GI Laliotis, K Dibs, N Mladkova, ... Journal of Clinical Oncology 39 (15_suppl), 6038-6038, 2021 | 6 | 2021 |
| Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial YL Verschoor, J van de Haar, JG van den Berg, JW van Sandick, ... Nature medicine, 1-12, 2024 | 5 | 2024 |
| Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up SV Lindskrog, K Birkenkamp-Demtröder, I Nordentoft, G Laliotis, P Lamy, ... Clinical Cancer Research 29 (23), 4797-4807, 2023 | 5 | 2023 |
| Effective identification of RNA-binding proteins using RNA Immunoprecipitation GI Laliotis, PN Tsichlis Protocols. io, dx 10, 2020 | 5 | 2020 |
| Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan. E Oki, D Kotani, Y Nakamura, S Mishima, H Bando, H Yukami, K Ando, ... Journal of Clinical Oncology 41 (16_suppl), 3521-3521, 2023 | 4 | 2023 |
| Abstract PO010: The inhibition of IWS1 phosphorylation promotes genomic instability, the cGAS/STING pathway activation and PD-L1 levels, through the U2AF2 alternative RNA … GI Laliotis, E Chavdoula, A Kaba, A La Ferlita, V Anastas, A Orlacchio, ... Cancer Immunology Research 9 (2_Supplement), PO010-PO010, 2021 | 4 | 2021 |
| IWS1 phosphorylation promotes cell proliferation and predicts poor prognosis in EGFR mutant lung adenocarcinoma patients, through the cell cycle-regulated U2AF2 RNA splicing GI Laliotis, E Chavdoula, MD Paraskevopoulou, AD Kaba, A La Ferlita, ... bioRxiv, 2020.07. 14.195297, 2020 | 4 | 2020 |
| Utility of ctDNA in predicting outcome and pathological complete response in patients with bladder cancer as a guide for selective bladder preservation strategies. L Dyrskjøt, G Laliotis MD, PhD, I Nordentoft, K Birkenkamp-Demtröder, ... Journal of Clinical Oncology 41 (6_suppl), 563-563, 2023 | 3 | 2023 |
| IWS1 phosphorylation controls nucleocytoplasmic export of type I IFNs and the sensitivity to oncolytic viruses, through U2AF2 RNA splicing GI Laliotis, A Kenney, E Chavdoula, A La Ferlita, V Anastas, J Yount, ... Mendeley Data 1, 10.17632, 2021 | 3 | 2021 |
| Abstract PO-011: IWS1 phosphorylation promotes tumor growth and predicts poor prognosis in EGFR mutant lung adenocarcinoma patients, through the epigenetic regulation of U2AF2 … GI Laliotis, E Chavdoula, MD Paraskevopoulou, A Kaba, A La Ferlita, ... Cancer Research 80 (23_Supplement), PO-011-PO-011, 2020 | 3 | 2020 |
| Abstract LB-183: Sensitivity of cancer cells to oncolytic viruses is defined by IWS1 phosphorylation dependent epigenetic regulation of U2AF2 splicing and nucleocytoplasmic … GI Laliotis, AD Kenney, A Orlacchio, V Coppola, JS Yount, PN Tsichlis Cancer Research 80 (16_Supplement), LB-183-LB-183, 2020 | 3 | 2020 |
Shruti SharmaNatera Inc., The University of ChicagoVerified email at natera.com
